CTOs on the Move

Milestone Scientific

www.milestone.com

 
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone`s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone`s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.milestone.com
  • 425 Eagle Rock Avenue Suite 403
    Roseland, NJ USA 07068
  • Phone: 973.535.2717

Executives

Name Title Contact Details

Similar Companies

Life Spine

Life Spine is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

West Texas Rehab Center

West Texas Rehab Center is a Abilene, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuMeDx

NeuMeDx, Inc. is a Bristol, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tri-Medical

Tri-Medical is a Lake Oswego, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LumiThera

At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.